Bio-Rad's Q4 Revenues Decline as Life Science Sales Slump

Bio-Rad's Q4 life science sales were hit by cutbacks in capital equipment spending by customers. The firm also was cautious in providing 2009 revenue guidance.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.